Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines

類似資料

• Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer
  著者:: Batista, N, 等
  出版事項: (2004)
• Comparison of apatinib and capecitabine (Xeloda) with capecitabine (Xeloda) in advanced triple-negative breast cancer as third-line therapy: A retrospective study
  著者:: Li, Yi-Hui, 等
  出版事項: (2018)
• Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines
  著者:: Berruti, A, 等
  出版事項: (2005)
• Xeloda (capecitabine) potentialities in the treatmentof cancer patients (review)
  著者:: N F Orel
  出版事項: (2003-10-01)
• Low-dose capecitabine (Xeloda) for treatment for gastrointestinal cancer
  著者:: Miger, Jasmine, 等
  出版事項: (2014)